
Norbert Sprenger
- Senior R&D Expert in the department of Gastrointestinal Health at the Nestlé Institute of Health Sciences investigating microbiome-host interactions
- Earned his PhD at the University of Basel (Switzerland) before continuing academic research related to functional complex glycans at the Universities of Zurich (Switzerland) and Stanford (Ca, USA)
- Dedicated the last 22 years to applied industrial research at Nestlé Research (Switzerland), which led to major insight and patentable innovations related to milk oligosaccharides for infant nutrition
- Publications include more than 66 peer-reviewed articles (h-index 32 in Scopus), over 65 international patent applications, and numerous presentations at international conferences and product launch/support events
- Core research interests are focused on understanding how dietary glycans and early life nutrition through their effects on microbe-host interactions drive the development of gut health and immune competence
- To this end "learning from nature" through the study of mother’s milk and specifically the biology of milk oligosaccharides is a central element
Articles from this author

So much better together: Pre- and probiotics to support infant gut microbiome and immune maturation

Human Milk Oligosaccharides, Important Milk Bioactives for Child Health: A Perspective

Temporal Evolution of Human Milk Oligosaccharides

Physiological significance of HMO: Why are they in mother’s milk?
Videos from this author

Human milk benefit research, more to learn? Norbert Sprenger

Milk Oligosaccharides – From Research to Pediatric Practice

Gut microbiome trajectory, immunity, and clinical implications

Gut Talk Series: HMOs and infant gut microbiome
Publications from this author

The Nest 52: The microbiome and synergies in the gut

Early Life Gut Microbiome Development in Bangladeshi Infants, Its Association with Food Intake and Health Outcomes

Safety and efficacy of a probiotic-containing infant formula supplemented with 2’-fucosyllactose: a double-blind randomized controlled trial

Human Milk Oligosaccharide-Stimulated Bifidobacterium Species Contribute to Prevent Later Respiratory Tract Infections